a- Absolute bioavailability:
It is the fraction of the administered dose that reaches the systemic circulation.
The absolute bioavailability is determined by comparing the amount of drug that reaches the systemic circulation after extravascular administration and after iv administration of the same dose of the same drug. This is because after iv administration the entire dose reaches the systemic circulation .
The absolute bioavailability can have values between 0 when no drug is absorbed at all, to 1.0 when all the administered dose reaches the systemic circulation. The absolute bioavailability does not have units since it is a fraction, and can be expressed as percent absorbed ( 0% to 100%)
b- Relative bioavailability:
The bioavailability of a drug product relative to the bioavailability of a second drug product that contains the same active drug moiety.
The relative bioavailability is determined by comparing the amount of the drug that reaches the systemic circulation after administration of an oral drug product and an oral reference standard formulation of the same active drug moiety.
The relative bioavailability can have any positive value. It can be more than one because the dosage form under investigation may have higher bioavailability than the reference standard formulation. The relative bioavailability is the ratio of the absolute bioavailability of different products for the same active drug.
The reference standard should contain the same active ingredient as the test product under investigation. The reference standard should be the formulation that has the highest bioavailabi]ity for the same active ingredient.
The reference standard should be administered by the same route as the formulation under investigation.
The reference standard for a drug is usually a formulation currently approved and marketed which is well accepted by the medical profession and has a long history of clinical use. The reference standard is usually the innovator's or the original manufacturer's product.
Bioavailability is a measure of the fraction of the administered dose that reaches the systemic circulation.
Absolute bioavailability is the fraction of the total dose that reaches the systemic circulation. It can have values between zero when the drug is not absorbed at all to 1 when all the administered dose reaches the systemic circulation. The absolute bioavailability can be expressed in terms of percentage (0% - 100%).
The relative bioavailability is the bioavailability of a drug product relative to the bioavailability of another drug product (reference standard preparation). The relative bioavailability can have any value above zero. It can be more than one when the product under investigation has bioavailability higher than that of the reference standard.